LESI | Print Page | Sign In | Join
Webinar: Yescarta: A Journey from Development to Licensing
Tell a Friend About This EventTell a Friend
 

hosted by the Industry-University-Government Interface (IUGI) Sector

12/12/2023
When: Tuesday, December 12, 2023
2:00 -3:00 pm ET
Where: Online
United States
Contact: webinars@les.org


Online registration is closed.
« Go to Upcoming Event List  

 

Yescarta: A Journey from Development to Licensing
hosted by the Industry-University-Government Interface (IUGI) Sector

Tuesday, December 12, 2023

2:00 pm - 3:00 pm Eastern

1:00 pm - 2:00 pm Central

12:00 pm - 1:00 pm Mountain

11:00 am - 12:00 pm Pacific

 

Program:
The presentation will address two topics related to licensing efforts of the National Cancer Institute (NCI). The first, a case study on the CAR-T product axicabtagene ciloleucel (sold under the brand name Yescarta®), will cover the development history of this ground-breaking therapy from the NCI technology transfer perspective. The second will be a brief discussion of NCI’s exclusive licensing practices as they concern important technologies in the adoptive cell therapy space. This will touch on how the NCI leverages federal licensing statute (e.g., 37 CFR § 404) to maximize utilization and public benefit of these inventions.

Speaker:

 

Andrew Burke, Senior Technology Transfer Manager, National Cancer Institute

Dr. Andrew Burke is a Senior Technology Transfer Manager for the National Cancer Institute’s (NCI) Technology Transfer Center. He joined the office in July 2013. In his current position, he manages a portfolio of intellectual property and related licenses covering the research of Dr. Steven A. Rosenberg, Chief of Surgery, and the investigators and staff of NCI Surgery Branch. His efforts in this regard have resulted in regional and national awards, including a 2020 and 2018 national citation for “Excellence in Technology Transfer” from the Federal Laboratory Consortium and the 2016 technology transfer “rookie of the year” award for the mid-Atlantic region. Prior to joining NIH technology transfer operations, Andrew was a Cancer Genetics and Signaling Fellow at NCI-Frederick in the lab of Dr. Brad St. Croix. Andrew received his Ph.D. in Cancer Biology from Wake Forest University School of Medicine under the direction of Drs. Frank and Suzy Torti with a dissertation describing the use of multiwalled carbon nanotubes for the photothermal treatment of cancer. He received a B.A. degree in Biology from Pepperdine University.



LES Members Price: FREE

(LES International Members please contact info@les.org for a code)

Non-Members: $69

Want to view this and all LES webinars (recorded and LIVE) for free  - Join LES Today!

Email Consent:  By registering for this event, you permit LES to use your email address to communicate with you regarding LES events and their other services. You will have the ability to unsubscribe from these communications going forward.


Sponsors

Connect with more than 500 intellectual capital management decision-makers and thought leaders around the world.  Join us at the LES 2025 Annual Meeting as a sponsor to promote your company and discover new business opportunities. Learn more

 

 
401 Edgewater Place, Suite 600, Wakefield, MA 01880
Phone: 703-234-4058

This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.